Cancer-Targeting Compound 1

CAS No. 1007581-62-5

Cancer-Targeting Compound 1( —— )

Catalog No. M33205 CAS No. 1007581-62-5

Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 692 Get Quote
5MG 908 Get Quote
10MG 1226 Get Quote
25MG 1766 Get Quote
50MG 2383 Get Quote
100MG 3132 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cancer-Targeting Compound 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
  • Description
    Cancer-Targeting Compound 1 is used in the research of hormone-?related cancer, extracted from patent WO 2008021331 A2.
  • In Vitro
    Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1007581-62-5
  • Formula Weight
    299.35
  • Molecular Formula
    C15H13N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(C)COC(=O)N1c1nc(cs1)-c1ccc(cc1)C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.
molnova catalog
related products
  • Thioguanine

    Thioguanine is an antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.

  • Ellagic acid-4-O-bet...

    Ellagic acid 4-O-β-D-xylopyranoside is a natural ellagitannin with antimicrobial activity.

  • F16

    F16 inhibits the growth of neu-overexpressing cells and the proliferation of mammary epithelial.